http://dspace.bsuedu.ru/handle/123456789/46276 Tue, 07 Apr 2026 18:40:57 GMT 2026-04-07T18:40:57Z http://dspace.bsuedu.ru/handle/123456789/46629 Title: Preclinical study of innovative peptides mimicking the tertiary structure of the α-helix B of erythropoietin Authors: Golubev, I. V.; Gureev, V. V.; Korokin, M. V.; Serdyuk, E. A.; Soldatova, V. A. Abstract: The aim of this study was to examine the effectiveness of innovative peptides obtained by addition of polypeptide motifs with antiaggregation activity (Arg-Gly-Asp, Lys-Gly-Asp and Pro-Gly-Pro) to a peptide mimicking the tertiary structure of the α-helix B of erythropoietin pHBSP (Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser) Wed, 01 Jan 2020 00:00:00 GMT http://dspace.bsuedu.ru/handle/123456789/46629 2020-01-01T00:00:00Z http://dspace.bsuedu.ru/handle/123456789/46586 Title: Medication adherence in patients with stable coronary artery disease in primary care Authors: Zyryanov, S. K.; Fitilev, S. B.; Vozzhaev, A. V.; Shkrebniova, I. I.; Shindryaeva, N. N. Abstract: Medication non-adherence in coronary outpatients exceeded 50%. High adherence was associated with more frequent use of fixed dose combinations and fewer pills taken by patient Wed, 01 Jan 2020 00:00:00 GMT http://dspace.bsuedu.ru/handle/123456789/46586 2020-01-01T00:00:00Z http://dspace.bsuedu.ru/handle/123456789/46585 Title: On the way from SARS-CoV-sensitive mice to murine COVID-19 model Authors: Soldatov, V. O.; Kubekina, M. V.; Silaeva, Yu. Yu.; Bruter, A. V.; Deykin, A. V. Abstract: The coronavirus disease 2019 (COVID-19) is a master killer which appeared suddenly and which has already claimed more than 200,000 human lives. In this situation, laboratories are in urgent need for a COVID-19 murine model to search for effective antiviral compounds Wed, 01 Jan 2020 00:00:00 GMT http://dspace.bsuedu.ru/handle/123456789/46585 2020-01-01T00:00:00Z http://dspace.bsuedu.ru/handle/123456789/46584 Title: Molecular docking, ADMET study and in vivo pharmacological research of N-(3,4-dimetoxyphenyl)-2-{[2-methyl-6-(pyridine-2-yl)-pyrimidin-4-yl]thio}acetamide as a promising anticonvulsant Authors: Severina, H. I.; Skupa, O. O.; Voloshchuk, N. I.; Saidov, N.; Bunyatyan, V. A. Abstract: The search for new anticonvulsants for epilepsy treatment with higher efficacy and better tolerability remains important. The aim of the present research was an in silico and in vivo pharmacological study of N-(3,4-dimethoxyphenyl)-2-((2-methyl-6-(pyridin-2-yl)pyrimidin-4-yl)thio)acetamide (Epirimil) as a promising anticonvulsant Wed, 01 Jan 2020 00:00:00 GMT http://dspace.bsuedu.ru/handle/123456789/46584 2020-01-01T00:00:00Z